Radiation May Indirectly Impair Growth Resulting in Reduced Standing Height via Subclinical Inflammation in Atomic-Bomb Survivors Exposed at Young Ages
Table 1
Data profile of 3,327 atomic bomb survivors included in analysis.
Variables
Sex
Male (1,143)
Female (2,184)
Both sexes (3,327)
Hiroshima (%)
714 (62.5)
1430 (65.5)
2144 (64.4)
Age at exposure (yr)(a)
12.6 (0, 25.0)
14.9 (0.1, 25.0)
14.1 (0, 25.0)
Bone marrow dose (Gy)(a)
0.533 (0, 4.12)
0.433 (0, 4.42)
0.468 (0, 4.42)
Standing height (cm)(b)
162.7 (6.13)
151.1 (5.39)
155.1 (7.90)
Weight (kg)(b)
54.8 (7.51)
48.8 (7.11)
50.9 (7.79)
BMI (kg/m2)(b)
20.7 (2.42)
21.3 (2.83)
21.1 (2.71)
Smoker (%)
617 (54.0)
207 (9.5)
824 (24.8)
Cancer (%)
56 (4.9)
182 (8.3)
238 (7.2)
Inflammatory diseases (%)
491 (43.0)
922 (42.2)
1413 (42.5)
Diabetes mellitus (%)
133 (11.6)
155 (7.1)
288 (8.7)
WBC (×102/mm3)(b)
66.7 (18.72)
55.7 (14.75)
59.5 (17.03)
Sialic Acid (mg/dL)(b)
68.6 (9.20)
67.9 (9.22)
68.2 (9.22)
ESR (mm/hour)(b)
11.4 (8.15)
20.0 (9.72)
17.1 (10.07)
1 globulin (%)(b)
3.4 (0.72)
3.3 (0.66)
3.3 (0.68)
2 globulin (%)(b)
9.4 (1.38)
9.6 (1.35)
9.5 (1.37)
Mean (range); mean (SD); all tests for comparisons between sexes are significant except for the Hiroshima rate and bone marrow dose using chi-square test for the rate (Hiroshima, smoker, cancer, inflammatory disease, and diabetes rates), using Wilcoxon rank sum test (age at exposure, bone marrow dose), or using two-sample -test for other continuous variables.
